NPIPB12
gene geneOn this page
Summary
NPIPB12 (nuclear pore complex interacting protein family member B12, HGNC:37491) is a protein-coding gene on chromosome 16p11.2, encoding Nuclear pore complex-interacting protein family member B12 (F8W0I5).
Predicted to be located in membrane.
Source: NCBI Gene 440353 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001395931
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37491 |
| Approved symbol | NPIPB12 |
| Name | nuclear pore complex interacting protein family member B12 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000169203 |
| Ensembl biotype | protein_coding |
| Entrez | 440353 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 5 nonsense_mediated_decay, 3 protein_coding, 1 retained_intron
ENST00000547235, ENST00000548346, ENST00000549733, ENST00000550665, ENST00000550690, ENST00000551448, ENST00000552123, ENST00000878929, ENST00000938250
RefSeq mRNA: 3 — MANE Select: NM_001395931
NM_001355401, NM_001395931, NM_001395932
Canonical transcript exons
ENST00000550665 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002339863 | 29483534 | 29485833 |
| ENSE00002405550 | 29505784 | 29506408 |
| ENSE00002407228 | 29505473 | 29505630 |
| ENSE00003491982 | 29491775 | 29491874 |
| ENSE00003575657 | 29495479 | 29495607 |
| ENSE00003624709 | 29491467 | 29491662 |
| ENSE00003642886 | 29487339 | 29487399 |
| ENSE00003668597 | 29487194 | 29487229 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.10.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 99.10 | gold quality |
| right uterine tube | UBERON:0001302 | 99.05 | gold quality |
| granulocyte | CL:0000094 | 99.00 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 98.96 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 98.96 | gold quality |
| cerebellar cortex | UBERON:0002129 | 98.93 | gold quality |
| sural nerve | UBERON:0015488 | 98.85 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.82 | gold quality |
| cerebellum | UBERON:0002037 | 98.81 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.80 | gold quality |
| spleen | UBERON:0002106 | 98.78 | gold quality |
| metanephros cortex | UBERON:0010533 | 98.65 | gold quality |
| right testis | UBERON:0004534 | 98.61 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.58 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 98.58 | gold quality |
| skin of abdomen | UBERON:0001416 | 98.49 | gold quality |
| skin of leg | UBERON:0001511 | 98.45 | gold quality |
| zone of skin | UBERON:0000014 | 98.42 | gold quality |
| left testis | UBERON:0004533 | 98.37 | gold quality |
| pituitary gland | UBERON:0000007 | 98.35 | gold quality |
| right lobe of liver | UBERON:0001114 | 98.34 | gold quality |
| Ammon’s horn | UBERON:0001954 | 98.34 | gold quality |
| transverse colon | UBERON:0001157 | 98.21 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.18 | gold quality |
| amygdala | UBERON:0001876 | 98.18 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.17 | gold quality |
| left uterine tube | UBERON:0001303 | 98.15 | gold quality |
| temporal lobe | UBERON:0001871 | 98.11 | gold quality |
| right ovary | UBERON:0002118 | 98.08 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 98.08 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.97 |
| E-ENAD-17 | no | 184.50 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB13 (ENSG00000198064), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member B12 — F8W0I5 (reviewed: F8W0I5)
All UniProt accessions (6): F8W0I5, E5RHP9, F5GWQ4, H0YIK9, H0YIQ3, H0YIQ5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the NPIP family.
RefSeq proteins (3): NP_001342330, NP_001382860, NP_001382861 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR048893 | NPB13-like_MII_rpt | Repeat |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409, PF20885
UniProt features (10 total): compositionally biased region 6, region of interest 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-F8W0I5-F1 | 44.73 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 8 (showing top):
chr16p11, JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP, JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN, DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS, DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS, HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP, HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP, GENES_CORRELATED_WITH_MYC_DELETION
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
623 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPIPB12 | DEPDC4 | Q8N2C3 | 505 |
| NPIPB12 | KRTAP4-8 | Q9BYQ9 | 479 |
| NPIPB12 | MTRNR2L3 | P0CJ70 | 476 |
| NPIPB12 | KRTAP5-7 | Q6L8G8 | 448 |
| NPIPB12 | CCSER2 | Q9H7U1 | 392 |
| NPIPB12 | NWD2 | Q9ULI1 | 361 |
| NPIPB12 | CLEC17A | Q6ZS10 | 358 |
| NPIPB12 | ZBTB8OS | Q8IWT0 | 348 |
| NPIPB12 | PHYHD1 | Q5SRE7 | 333 |
| NPIPB12 | GXYLT1 | Q4G148 | 322 |
| NPIPB12 | NIBAN3 | Q86XR2 | 321 |
| NPIPB12 | SGSM1 | Q2NKQ1 | 320 |
| NPIPB12 | PCDHB9 | Q9Y5E1 | 317 |
| NPIPB12 | CDC42EP1 | Q00587 | 316 |
| NPIPB12 | DDX51 | Q8N8A6 | 311 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A023PXQ4, A0A0U1RQI7, A6NJU9, A6NNC1, A8MRT5, A8MUU9, C9JG80, E2RYF6, E5RHQ5, F8W0I5, O13534, O59779, P08399, P0C732, P0C785, P0DTH6, P0DW28, P13208, P15941, P21787, P24856, P39564, P51861, P87269, Q00130, Q01456, Q12444, Q13117, Q1HVI8, Q27905, Q2EEQ3, Q4ZJY7, Q4ZJZ0, Q5SDL7, Q63661, Q69577, Q6B0Y1, Q6RY98, Q6ZQT0, Q6ZRX8
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2, A0A179HJB8, A4YDT1, C0SPB0, P0C7M7, P39062, Q6P461
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
350 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:29487337:A:AC | donor_gain | 1.0000 |
| 16:29487338:C:CC | donor_gain | 1.0000 |
| 16:29485832:ACCTG:A | acceptor_loss | 0.9900 |
| 16:29485834:C:CA | acceptor_loss | 0.9900 |
| 16:29485835:T:A | acceptor_loss | 0.9900 |
| 16:29487187:AACTT:A | donor_loss | 0.9800 |
| 16:29487192:A:AC | donor_gain | 0.9800 |
| 16:29487192:AC:A | donor_gain | 0.9800 |
| 16:29487193:C:CC | donor_gain | 0.9800 |
| 16:29487193:CC:C | donor_gain | 0.9800 |
| 16:29485829:CTGAC:C | acceptor_gain | 0.9700 |
| 16:29487338:CTTTG:C | donor_gain | 0.9700 |
| 16:29485834:C:CC | acceptor_gain | 0.9500 |
| 16:29487193:CCCA:C | donor_gain | 0.9400 |
| 16:29487193:CCCAG:C | donor_gain | 0.9400 |
| 16:29487333:CCTTA:C | donor_loss | 0.9400 |
| 16:29487334:CTTAC:C | donor_loss | 0.9400 |
| 16:29487335:TTAC:T | donor_loss | 0.9400 |
| 16:29487336:T:TG | donor_loss | 0.9400 |
| 16:29487337:A:AG | donor_loss | 0.9400 |
| 16:29487338:CT:C | donor_gain | 0.9400 |
| 16:29487331:CTCCT:C | donor_loss | 0.9300 |
| 16:29487332:TCCTT:T | donor_loss | 0.9300 |
| 16:29487034:CACGG:C | donor_gain | 0.9200 |
| 16:29487036:CGG:C | donor_gain | 0.9200 |
| 16:29487038:G:C | donor_gain | 0.9100 |
| 16:29485843:C:T | acceptor_gain | 0.8900 |
| 16:29487546:CAGT:C | donor_gain | 0.8900 |
| 16:29487228:ATCTG:A | acceptor_loss | 0.8800 |
| 16:29487229:TCTGA:T | acceptor_loss | 0.8800 |
AlphaMissense
3851 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1003472224 (16:29497755 C>G), RS1003608244 (16:29495019 C>T), RS1005166021 (16:29499304 C>A,T), RS1010915699 (16:29492777 A>G,T), RS1011301459 (16:29485627 C>T), RS1012323413 (16:29499142 T>A), RS1012767784 (16:29505893 T>G), RS1012864331 (16:29492456 A>C), RS1015155980 (16:29499326 A>G), RS1015187304 (16:29507286 C>T), RS1020945928 (16:29493016 C>T), RS1021041961 (16:29486944 C>T), RS1027911425 (16:29495114 G>C), RS1028275209 (16:29499153 G>C,T), RS1029366039 (16:29504567 A>C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Particulate Matter | affects cotreatment, increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.